Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

70 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Safety and pharmacokinetics of oseltamivir at standard and high dosages.
Dutkowski R, Smith JR, Davies BE. Dutkowski R, et al. Int J Antimicrob Agents. 2010 May;35(5):461-7. doi: 10.1016/j.ijantimicag.2009.12.023. Epub 2010 Mar 1. Int J Antimicrob Agents. 2010. PMID: 20189775 Clinical Trial.
Possible clinical benefit in severe influenza infections could be investigated at dosages higher than those currently recommended....
Possible clinical benefit in severe influenza infections could be investigated at dosages higher than those currently recommended....
Absence of adverse effects of oseltamivir on sleep: a double-blind, randomized study in healthy volunteers in Japan.
Uchimura N, Kuwahara H, Kumagai Y, Mishima K, Inoue Y, Rayner CR, Toovey S, Davies BE, Hosaka Y, Abe M, Prinssen EP. Uchimura N, et al. Among authors: davies be. Basic Clin Pharmacol Toxicol. 2011 Oct;109(4):309-14. doi: 10.1111/j.1742-7843.2011.00726.x. Epub 2011 Jun 29. Basic Clin Pharmacol Toxicol. 2011. PMID: 21592308 Free article. Clinical Trial.
Pharmacokinetics and Safety of Single Intravenous Doses of JNJ-54452840, an Anti-β1-Adrenergic Receptor Antibody Cyclopeptide, in Healthy Male Japanese and Caucasian Participants.
Nnane IP, Plotnikov AH, Peters G, Johnson M, Kojak C, Vutikullird A, Ariyawansa J, De Vries R, Davies BE. Nnane IP, et al. Among authors: davies be. Clin Pharmacokinet. 2016 Feb;55(2):225-36. doi: 10.1007/s40262-015-0309-8. Clin Pharmacokinet. 2016. PMID: 26242382 Clinical Trial.
Lack of age and gender effects on single-dose pharmacokinetics of tomopenem (RO4908463/CS-023), a novel carbapenem.
Mallalieu NL, Lennon S, Guy T, Liu M, Luedin E, Davies BE. Mallalieu NL, et al. Br J Clin Pharmacol. 2009 Apr;67(4):469-72. doi: 10.1111/j.1365-2125.2009.03367.x. Br J Clin Pharmacol. 2009. PMID: 19371322 Free PMC article. Clinical Trial.
CONCLUSIONS: While some PK parameters were statistically different among the three groups, the differences were mostly minor and unlikely to be clinically meaningful. The difference in the PK can be largely attributed to the difference in creatinine clearance of the …
CONCLUSIONS: While some PK parameters were statistically different among the three groups, the differences were mostly minor and unlikely to …
Pharmacokinetics and safety of coadministered oseltamivir and rimantadine in healthy volunteers: an open-label, multiple-dose, randomized, crossover study.
Cirrincione-Dall G, Brennan BJ, Ballester-Sanchis RM, Navarro MT, Davies BE. Cirrincione-Dall G, et al. Among authors: davies be. J Clin Pharmacol. 2012 Aug;52(8):1255-64. doi: 10.1177/0091270011412960. Epub 2011 Oct 30. J Clin Pharmacol. 2012. PMID: 22039289 Clinical Trial.
Effect of oseltamivir treatment on anticoagulation: a cross-over study in warfarinized patients.
Davies BE, Aceves Baldó P, Lennon-Chrimes S, Brewster M. Davies BE, et al. Br J Clin Pharmacol. 2010 Dec;70(6):834-43. doi: 10.1111/j.1365-2125.2010.03780.x. Br J Clin Pharmacol. 2010. PMID: 21175439 Free PMC article. Clinical Trial.
Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations.
Davies BE. Davies BE. J Antimicrob Chemother. 2010 Apr;65 Suppl 2(Suppl 2):ii5-ii10. doi: 10.1093/jac/dkq015. J Antimicrob Chemother. 2010. PMID: 20215135 Free PMC article. Review.
As the potential for drug interactions is low, oseltamivir is also suitable for use in patients with co-morbid conditions who are likely to be receiving concomitant medications....
As the potential for drug interactions is low, oseltamivir is also suitable for use in patients with co-morbid conditions who are likely to …
Effect of impaired renal function on the pharmacokinetics of tomopenem (RO4908463/CS-023), a novel carbapenem.
Mallalieu NL, Lennon S, Liu M, Kirkpatrick C, Robson R, Luedin E, Davies BE. Mallalieu NL, et al. Antimicrob Agents Chemother. 2008 Jul;52(7):2360-6. doi: 10.1128/AAC.01249-07. Epub 2008 Apr 28. Antimicrob Agents Chemother. 2008. PMID: 18443123 Free PMC article. Clinical Trial.
Pharmacokinetics and safety of gadobenate dimeglumine (multihance) in subjects with impaired liver function.
Davies BE, Kirchin MA, Bensel K, Lorusso V, Davies A, Parker JR, Lafrance ND. Davies BE, et al. Invest Radiol. 2002 May;37(5):299-308. doi: 10.1097/00004424-200205000-00008. Invest Radiol. 2002. PMID: 11979156 Clinical Trial.
70 results
Jump to page
Feedback